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Abstract: The operation of illicit drug markets 
is dependent on a chain of events with 
a global span. At each stage of the process, 
from the production to the trafficking through 
to the consumption and the derived profits, 
the health and security of different countries 
is compromised by organised crime groups.
This paper looks at EU policies and responses 
to the production and trafficking of illicit 
drugs, set within the global context. It 
considers the different strategic areas where 
these challenges are addressed, the EU 
structures involved, and some of the key 
measures currently being implemented 
by the EU and its international partners. 
Drug supply reduction issues arise in many 
policy areas, including illicit drug policy, 
security, organised crime, and maritime and 
regional cooperation policy. Issues related 
to drug production and trafficking arise in 
the work of several institutions, bodies and 
EU agencies. The operation of smuggling 
routes challenges the security of the EU in 
different ways and measures have been 
adopted to counteract these problems. 
These include developing intelligence-led 
policing and improved border management 
and surveillance as well as legislative tools to 
target criminal profits. The EU is involved in 
a range of projects and initiatives around the 
world designed to reduce the supply of illicit 
drugs, including capacity-building initiatives 
targeting smuggling routes and measures to 
support economic, legislative and monitoring 
infrastructural development. 
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I Summary
This EMCDDA Paper presents the main components of the 
European Union’s (EU’s) approach to drug supply reduction 
in an accessible way. It is a descriptive introductory guide to 
the area and considers the policy context, key structures and 
responses involved in EU action against the production and 
trafficking of illicit drugs.
Drug supply reduction issues arise in many areas of EU policy, 
including illicit drug policy, security, organised crime, and 
maritime and regional cooperation policy.
In the area of supply reduction the EU drugs strategy (2013–
20) and action plan (2013–16) identify several challenges. 
These include the dynamic nature of illicit drugs markets, 
changes in trafficking routes, and the role of cross-border 
organised crime and new technologies in the trafficking 
of illicit drugs and new psychoactive substances (NPS). 
The importance of preventing the diversion of drug precursors 
and cutting agents from licit industry that can be used to 
manufacture illicit drugs is also noted. The strategy responds to 
these challenges through its objective to disrupt drug markets 
and limit the availability of illicit drugs.
The production and trafficking of drugs are key issues in the 
European Agenda on Security 2015–20. Drug smuggling 
has been identified as one of the activities contributing to 
organised cross-border crime. It challenges border control and 
the movement of people and goods and is a financing tool for 
terrorist and organised crime groups.
Through the EU policy cycle for organised and serious 
international crime (‘the policy cycle’), EU Member States (MS) 
coordinate common priorities and operational actions. The 
Standing Committee on Operational Cooperation on Internal 
Security (COSI) steers this process and brings together MS 
law enforcement officials, the Commission and specialised EU 
agencies. It targets available resources in view of immediate, 
mid-term and long-term security threats and risks. Amongst 
the priorities in the 2014–17 policy cycle, three directly 
concern drug trafficking. These are reducing the production and 
trafficking of cocaine, heroin and synthetic drugs.
The EU’s Maritime Security Strategy and action plan address 
a range of problems, including drug supply reduction, that 
undermine the EU’s security and trade routes. As over 70 % of 
the EU’s external borders are maritime, these problems pose 
significant threats. The action plan focuses on preventing drug 
trafficking, enhancing port and maritime security, developing 
maritime surveillance, coordinating maritime patrolling among 
MS, and increasing law enforcement operations coordinated 
by the Maritime Analysis Operations Centre — Narcotics 
(MAOC-N).
The EU is actively engaged in ongoing political dialogues with 
third countries in its immediate geographical neighbourhood 
and other parts of the world though EU delegations and the 
European External Action Service (EEAS). This process involves 
working with other regions and countries to achieve common 
goals. Drug issues often feature in these political conversations 
and are a part of various EU-level policy documents including, 
drugs-specific and broader strategies, regional programmes, 
and political declarations and agreements.
Issues related to drug production and trafficking arise in 
the work of different EU institutions, bodies and agencies. 
Principally, this includes the EU Parliament, the Council of the 
European Union (the Council), the European Commission and 
specialised EU agencies.
Globally, 500 million cargo containers are shipped annually. 
The United Nations Office on Drugs and Crime (UNODC) 
and the World Customs Organization (WCO) run the Cargo 
Container Programme (CCP). It enhances interdiction capacity 
building by the establishment of Port Control Units (PCUs).
Since 2009 the European Commission has been involved 
in implementing the Cocaine Route Programme. It supports 
regional law enforcement and judicial cooperation in countries 
on the cocaine trafficking route through eight projects 
addressing drug interdiction, targeting the proceeds of crime 
and enhancing information exchange. Similarly, through the 
ongoing projects of the Heroin Route Programme the EU works 
in partnership with different organisations and governments 
impacted by the smuggling routes used by criminals.
With funding from the EU and a consortium of MS, the 
Border Management Programme in Central Asia aims to 
contribute to the security of Central Asian countries. It involves 
implementing integrated border management, enhancing 
the management of the movement of people and goods at 
border crossing points and developing the capacity of border 
agencies.
The Paris Pact Initiative involves over 70 countries and 
several international organisations in a partnership approach 
to address the trafficking and consumption of opiates from 
Afghanistan. Through the Vienna Declaration the pact has set 
out support for regional initiatives to address opiate trafficking 
from Afghanistan, detecting and blocking financial flows linked 
to the trade, preventing the diversion of drug precursors, and 
reducing drug abuse and dependence.
The International Narcotics Control Board (INCB) monitors 
global trade in drug precursors used for the illicit manufacture 
of drugs. Central National Authorities operate the INCB’s 
Pre-Export Notification system. The INCB also runs two 
ongoing international projects (Cohesion and Prism) 
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to monitor trade in drug precursors used for the illicit 
manufacture of drugs.
Alternative development in countries impacted by the 
cultivation, production and trafficking of illicit drugs is a core 
part of the EU’s international cooperation and it supports 
this through various financial instruments. For example, the 
Development and Cooperation Instrument (DCI) supports 
measures in Afghanistan and Latin America.
Several organisations operate initiatives aimed at depriving 
organised crime groups of the profits from drug trafficking. The 
Financial Action Task Force develops standards and promotes 
the implementation of legislative and regulatory tools to tackle 
money laundering and terrorist financing. The World Bank 
Group and the UNODC operate the Stolen Asset Recovery 
Initiative. It is the main international programme focused on 
the recovery of public assets stolen by corrupt government 
officials in developing countries.
Globally, amphetamine-type stimulants are, after cannabis, 
the second most consumed illicit drugs and the market for 
them is increasingly interlinked with the use of NPS. UNODC’s 
Global Synthetics Monitoring: Analyses, Reporting and Trends 
(SMART) programme has three aims: 1) help MS build capacity 
to collect and manage data on synthetic drugs, such as 
information from law enforcement; 2) increase understanding 
of drug problems through reporting and early warning; 3) 
support the development of evidence-based drug policies.
I Policy areas
The operation of illicit drug markets involves a chain of events 
with a global span. Drugs are produced within and outside 
Europe and create a range of security and health issues in 
the countries impacted by different aspects of the trade from 
manufacturing to consumption. Tackling these problems 
is a challenge for the global community that involves all 
countries affected. For this reason, drug supply reduction is 
part of several policy areas at the EU level, where a number of 
approaches are followed simultaneously. This paper looks at 
the different EU policy areas where illicit drug issues mainly 
arise and the main EU structures involved, and sets out some 
of the responses that are being used to address the production 
and trafficking of illicit drugs by the EU and its partners. 
A comprehensive analysis of the illicit drug trade in Europe and 
the responses to it is available in the joint EMCDDA-Europol EU 
Drug Markets Report (see box) (EMCDDA and Europol, 2016).
The present EMCDDA Paper presents the main components 
of the EU’s approach to drug supply reduction in an accessible 
way. It is designed as an introductory guide to the area and 
provides a clear and concise overview of EU drug supply 
reduction policies and responses to help those working in the 
area nationally who are new to the issues. It also functions 
as an orienting source of information for researchers and 
allows interested members of the general public to gain an 
understanding of EU action to reduce the supply of illicit drugs. 
The Paper consists of four sections that can be read together 
or consulted individually. The first two sections address the 
different policy areas where drug supply reduction arises 
and the main EU structures involved. The other two sections 
present examples of the measures being implemented to 
target drug markets within the EU, the trafficking of drugs, 
and the wider context within which drug smuggling occurs. 
Common abbreviations are listed at the end of the document 
alongside references.
I Drug policy
Drug supply reduction issues arise in many areas of EU policy, 
including illicit drug policy, security, organised crime, and 
maritime and regional cooperation policy. While the main 
elements of EU drug supply reduction policy are expressed in 
The 2016 EU Drug Markets Report provides a unique 
insight into the operation of illicit drug markets in the EU. 
The report assesses the impact of the drug market on 
society and the factors driving it. It explores the markets 
for cannabis, heroin, cocaine, amphetamines, MDMA 
and NPS. Understanding these hidden markets, and 
the actors involved, is essential to making sound policy 
decisions with lasting impact. The report combines 
the analytical power of the EMCDDA’s drug monitoring 
system with Europol’s operational intelligence on trends 
in organised crime. 
Learn more: http://www.emcdda.europa.eu/start/2016/
drug-markets#pane1
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the EU drugs strategy 2013–20 and its action plan 2013–16, 
important issues are also addressed in a range of other policy 
areas that have a different focus. Some of the key strategic 
areas where actions to reduce the supply of illicit drugs are 
elaborated are discussed below.
The framework provided by the EU drugs strategy 2013–20 
and action plan (2013–16) complements MS national 
strategies and supports joint actions. The strategy seeks to 
ensure effective and efficient use of available resources. Drug 
supply reduction is one of the two pillars around which the 
strategy is built alongside drug demand reduction and the 
cross-cutting areas of coordination, international cooperation, 
and information, research, monitoring and evaluation. In 
the area of supply reduction, several challenges have been 
identified (see Table 1). These include the dynamic nature of 
illicit drugs markets, changes in trafficking routes, and the role 
of cross-border organised crime and new technologies in the 
trafficking of illicit drugs and NPS. In addition, the strategy 
notes the importance of preventing the diversion of drug 
precursors and cutting agents from licit trade that can be 
used for the illicit manufacture of drugs. It responds to these 
challenges through its objective to disrupt drug markets and 
limit the availability of illicit drugs (Council of the European 
Union, 2012a).
The overarching objective of the EU drugs strategy 2013–20 in 
the area of supply reduction is a measurable reduction of the 
availability of illicit drugs, through:
 § the disruption of illicit drug trafficking;
 § the dismantling of organised crime groups that are involved 
in drug production and trafficking;
 § efficient use of the criminal justice system;
 § effective intelligence-led law enforcement and increased 
intelligence sharing;
 § an EU-level emphasis on large-scale, cross-border and 
organised drug-related crime.
Both the policy cycle and the EU drugs strategy contribute 
to the implementation of the European Agenda on Security 
(European Commission, 2013). These strategic tools are 
designed to complement each other, providing effective 
coordination of EU-level policy actors and ensuring that all 
aspects of drug supply reduction are addressed.
I Security policy
The production and trafficking of drugs are key issues in 
the European Agenda on Security 2015–20 (Council of the 
European Union, 2015a). Drug smuggling has been identified 
as one of the activities contributing to organised cross-border 
crime. It challenges border control and the movement of 
people and goods and is a financing tool for terrorist and 
organised crime groups. These activities undermine the area of 
freedom, security and justice created by the EU. The European 
Agenda on Security notes the dynamic nature of drug markets, 
in particular the production of NPS within and outside the EU. 
It also underlines the key role played by the EU policy cycle 
on organised and serious international crime against drug 
trafficking in security policy. The European Agenda on Security 
recognises the importance of security issues in dialogues 
with third countries and that the European Neighbourhood 
Policy (ENP) provides a means to achieve this. It also notes 
the European Maritime Security Strategy’s role in addressing 
drug trafficking as a security issue. This includes, for example, 
the use of coordinated patrol actions and interoperable 
information systems. Similarly, it supports the approach taken 
in the European Agenda on Migration, given the links between 
organised crime groups involved in the trafficking of drugs and 
the facilitation of illegal migration (European Commission, 
2015a; 2015b).
I The policy cycle
Through the EU policy cycle on organised and serious 
international crime (the policy cycle), EU MS coordinate 
common priorities and operational action. The Standing 
Committee on Operational Cooperation on Internal Security 
(COSI) steers this process and brings together MS law 
enforcement officials, the Commission and specialised EU 
agencies. The policy cycle provides a methodology for an 
TABLE 1
Distribution of objectives and actions in the EU drugs strategy and action plan
Drug demand 
reduction 
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intelligence-led approach to security issues such as organised 
crime and the production and trafficking of illicit drugs. 
It targets available resources in view of immediate, mid-term 
and long-term security threats and risks. Amongst the priorities 
in the 2014–17 policy cycle, three directly concern drug 
trafficking: reducing the production and trafficking of cocaine, 
heroin and synthetic drugs.
The process involves the Presidency of the Council, COSI 
and the European Commission developing a Policy Advisory 
Document based on the Serious Organised Crime Threat 
Assessment (SOCTA) developed by Europol. This document is 
then used by the Council to agree conclusions, drafted by COSI, 
which define the crime priorities in the policy cycle — it is the 
Council’s responsibility to make political decisions in the Justice 
and Home Affairs area. Subsequently, Multi-annual Strategic 
Plans (MASPs) are established and implemented through 
Operational Action Plans (OAPs), both of which are developed 
by the MS, the Commission and the EU agencies under COSI’s 
coordination. Following this, project groups are established to 
manage each operational action plan (see Figure 1) (Council of 
the European Union, 2010; EMCDDA and Europol, 2013).
I Maritime security
The EU has one of the world’s most open trading economies, 
with links extending to all corners of the globe. Many factors, 
including weak governance structures and state destabilisation 
in countries near the EU, enhance the opportunities for 
maritime smuggling and piracy. Given that over 70 % of 
the EU’s external borders are maritime, these factors pose 
significant threats to the Union’s interests. The EU’s Maritime 
Security Strategy and its accompanying action plan seek to 
address the range of issues, including drug supply reduction, 
that undermine the EU’s security and trade routes. The strategy 
identifies drug trafficking as one of a number of threats that 
Europe faces. Its action plan sets out areas to address this 
issue, including preventing drug trafficking, enhancing port 
and maritime security, developing maritime surveillance, 
coordinating maritime patrolling among MS and increasing law 
enforcement operations coordinated by the Maritime Analysis 
Operations Centre — Narcotics (MAOC-N) (Council of the 
European Union, 2014a; 2014b).
I A regional approach
The EU is actively engaged in ongoing political dialogues with 
third countries in its immediate geographical neighbourhood 
and other parts of the world through EU delegations and 
the European External Action Service (EEAS). This process 
involves working with other regions and countries to achieve 
common goals, such as strengthening democracy and the 
rule of law, supporting trade, and promoting sustainable and 
alternative development. Drug issues often feature in these 
political conversations and are a feature of various EU-level 
policy documents including, drugs-specific and broader 
strategies, regional programmes, and political declarations 
and agreements. The approach taken in these documents 
reflects the principles and objectives of EU drug policy set out 
in the EU drugs strategy (2013–20) and other key documents 
addressing drug problems. Action 38 of the EU action plan 
on drugs (2013–16) seeks to ‘reinforce cooperation and 
update and implement dialogues, declarations and EU drugs 
action plans with partners, including: (a) acceding countries, 
candidate countries and potential candidates; (b) European 
Neighbourhood Policy countries; (c) the United States of 
America, the Russian Federation; (d) other countries or regions 
of priority notably: Afghanistan and Pakistan, Central Asian 
republics, China, Latin America and the Caribbean (CELAC), 
and Africa, in particular West Africa’ (Council of the European 
Union, 2013a).
The EU’s regional approach to ongoing cooperation and 
dialogue on drugs can be seen, for example, from the aims 
of the EU-Central Asia Action Plan on Drugs (2014–20). It 
recognises the security threat common to the Central Asian 
countries and the EU from drug trafficking from Afghanistan, 
particularly in the context of the International Security 
Assistance Force withdrawal (Council of the European Union, 
2013b). The EU-Western Balkans commitment to fight 
against drugs called for the continued implementation of 
the 2009–13 action plan on drugs for the region. Following 
the EU’s balanced approach to drug policy — between 
supply and demand reduction measures — the action plan 
FIGURE1
The policy cycle on organised and serious crime
Source: EMCDDA and Europol, 2016.
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supports a range of approaches. This includes addressing the 
rapid changes in drug trafficking routes and preventing the 
diversion of precursor chemicals (Council of the European 
Union, 2009; 2014c). The Community of Latin American 
and Caribbean States (CELAC) is a political cooperation 
mechanism established in 2010, bringing together 33 Latin 
American and Caribbean countries. A wide range of demand 
and supply issues are addressed in the EU-CELAC action plan 
(2013–15), which, for example, supports actions against illicit 
trade in and diversion of drug precursors, cooperation against 
money laundering and alternative development (Council 
of the European Union, 2013c; 2015b). The overarching 
framework for political cooperation between the EU and Africa 
is provided by the joint Africa-EU strategy and its roadmap 
(2014–17). Here, European and African leaders have stated 
their commitment to addressing shared security challenges, 
including efforts to address drug trafficking (Council of the 
European Union, 2007; 2014d). Afghanistan is the largest 
recipient of aid from the EU, which has made a long-term 
commitment to working with the country. As Afghanistan is 
the world’s largest cultivator of illicit opium, supporting efforts 
to tackle the production and trafficking of illicit drugs are 
established as objectives in the EU strategy in Afghanistan 
(2014–16) (Council of the European Union, 2014e).
I The EU institutional system
Issues related to the production and trafficking of illicit drugs, 
including supply, arise in the work of various institutions, 
bodies and EU agencies (see Figure 2). These structures are 
responsible for designing and implementing the strategies 
that direct the EU’s drug supply reduction measures, as 
well as the EU’s cooperation with its international partners. 
Together, these different EU structures function to provide 
a comprehensive set of measures to reduce the supply of 
illicit drugs. The role played by these different EU structures is 
discussed in the section below.
I Institutions
The EU has several institutions (1), with drug supply reduction 
issues mainly arising in the work of the European Parliament, 
the Council of the European Union and the European 
Commission. The European Parliament’s functions include 
passing laws, in conjunction with the Council of the European 
Union, through the ordinary legislative procedure that applies 
to many areas of EU law, approving the EU budget and 
(1)  The European Parliament, the European Council, the Council of the European 
Union (‘the Council’), the European Commission, the Court of Justice of the 
European Union, the European Central Bank and the European Court of 
Auditors. 
discussing EU policies (European Parliament, 2013). Drug 
issues arise in different areas of the Parliament’s work when, 
for example, it considers internal security matters or relations 
with non-EU countries (‘third countries’).
The Council of the European Union (the Council) performs 
a diverse set of functions. It adopts legislation (often in 
conjunction with the European Parliament), plays a policy 
coordination role for the MS, devises the EU Common Foreign 
and Security Policy (CFSP), signs off on agreements between 
the EU and third countries, and adopts the EU’s annual budget 
(Council of the European Union, 2013d). Drug issues arise 
in the work of many Council working groups, in particular 
COSI and the Horizontal Working Party on Drugs (HDG). COSI 
plays a leading role in defining, implementing, monitoring 
and evaluating EU activities in the policy cycle (Council of the 
European Union, 2010). The HDG plays a central role in the 
development of EU drugs strategies and action plans and its 
purview encompasses all areas of drug demand reduction and 
drug supply reduction (Council of the European Union, 1999).
The European Commission has a wide range of tasks 
(European Commission, 2015c). This includes the right of 
initiative to propose new legislation, as well as ensuring MS 
correctly implement EU laws. Alongside drafting the EU’s 
annual budget and overseeing how funds are used, the 
Commission undertakes international negotiations on behalf of 
the EU. The Commission consists of 33 departments known as 
Directorates-General (DGs) and drug supply reduction issues 
arise in different areas of its work. Additionally, the Commission 
is responsible for managing the EU’s security policy, migration 
and asylum policy, and the financing of activities in the home 
affairs area. The Commission is responsible for specialised 
EU agencies like the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA) and the European Union’s law 
enforcement agency (Europol), which work under the DG for 
Migration and Home Affairs. In the area of internal security, the 
Commission’s work covers the fight against organised crime 
and fostering cooperation among police forces and managing 
the EU’s borders. The Commission addresses drug control 
policy in a broad sense, covering issues under drug demand 
reduction and drug supply reduction. These include the 
monitoring and evaluation of EU MS measures directed at the 
reduction of drug use and the prevention of drug-related crime 
and drug trafficking. The Commission proposes measures for 
the control of NPS and ensures the implementation of EU laws 
to prevent the diversion of drug precursors. It also promotes 
European cooperation in addressing drug problems through 
the provision of financial assistance.
The Lisbon Treaty called for the establishment of the post 
of High Representative of the Union for Foreign Affairs 
and Security Policy (TEU article 15) and the EEAS (TEU 
article 27) (Council of the European Union, 2012b). The High 
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Representative is in charge of the EEAS and is responsible for, 
among other things, conducting the EU’s CFSP, developing 
policy proposals and chairing the Foreign Affairs configuration 
of the Council. Assisting the High Representative, the EEAS 
develops policy proposals and implements them after 
approval from the Parliament and the Council (European 
External Action Service, 2015). The EEAS oversees the EU 
delegations in more than 130 countries, coordinates the EU’s 
external action and is the permanent chair of the Council’s 
Political and Security Committee, which is responsible for 
the CFSP. Additionally, the EEAS carries out the strategic 
programming for EU external assistance, which is then 
implemented by EuropeAid.
I Agencies
The EMCDDA provides the EU and its MS with factual, 
objective, reliable and comparable information at European 
level concerning drugs and drug addiction and their 
consequences (EMCDDA, 2010). It collects data from its Reitox 
national focal points on a range of drug supply reduction and 
demand reduction issues. This includes information about drug 
law offences, drug seizures, drug purity and potency, as well 
as retail prices for drugs (EMCDDA and Europol, 2016). It also 
operates the Early Warning System on NPS in conjunction with 
Europol and conducts risk assessments.
In the drugs supply reduction area, Europol provides 
intelligence information, collects data and runs information 
systems on the activities of organised crime groups, the 
substances they manufacture, the locations and equipment 
they use, and their smuggling and transportation methods. 
It carries out threat assessments in different regions and 
produces the SOCTA and the EU Terrorism Situation and 
Trend Report, which inform policymaking and planning 
processes, such as the policy cycle. It works with EU MS 
through Europol national units and functions as a specialist 
information hub, supporting policing operations throughout 
the EU. It operates the Europol Criminal Assets Bureau and 
the Europol Cyber Crime Centre. Europol provides secretariat 
services for the Camden Asset Recovery Inter-Agency 
Network (CARIN). It facilitates action under the EU policy cycle 
through its specialised information services and supports the 
European Multidisciplinary Platform against Criminal Threats 
(EMPACT) through which coordinated operational actions are 
implemented.
Drug supply reduction issues arise in several areas of the work 
of the European Agency for the Management of Operational 
Cooperation at the External Borders of the Member States of 
the European Union (Frontex). It carries out joint operations 
at the EU’s external (air, land and sea) borders, provides 
training and undertakes risk analysis. It works with the EU’s 
international partners, such as the UNODC and the Central 
Asia Border Security Initiative. Frontex is responsible for 
coordinating the European Border Surveillance System called 
Eurosur (Frontex, 2015a; 2015b).
Cepol, the European Police College, is involved in building 
police cooperation across the EU. It provides a wide range 
of training courses relevant to different aspects of supply 
reduction and security activities. In conjunction with Europol, 
it provides training to national law enforcement officers on the 
dismantling of clandestine laboratories used to manufacture 
illicit drugs. It facilitates the implementation of the policy cycle 
through the provision of specialised training workshops on the 
development of strategic plans and projects. Cepol works with 
MS police training colleges to deliver training (Cepol, 2015).
Eurojust is the EU judicial cooperation unit. Its work covers the 
activities of organised crime groups, such as drug trafficking 
and money laundering. It can request MS to investigate or 
prosecute a crime, to work together and to establish a Joint 
Investigation Team (JIT). It works closely with the European 
Judicial Network and Europol, and assists national authorities 
with the use of mutual legal assistance and mutual recognition 
legal tools (e.g. European arrest warrant). Eurojust also 
works with EU MS on the use and coordination of controlled 
deliveries of illicit drugs (Eurojust, 2015a).
FIGURE 2
Main EU structures addressing drug supply reduction 
issues
Source: EMCDDA and Europol, 2016.
EMCDDA PAPERS I Drug supply reduction: an overview of EU policies and measures
8 / 24
I Disrupting European drug markets
The operation of drug trafficking routes challenges the security 
of the EU in different ways. It can compromise the safety of 
commercial cargo transport routes, while the profits derived 
from the illicit drugs industry can infiltrate the financial system 
and be used to finance other illegal and terrorist activities. 
The EU has adopted different measures to counteract these 
challenges. These range from developing intelligence-led 
policing and surveillance to legislative and other tools to target 
criminal profits. This section of the Paper sets out examples 
of some of the main responses being used to target European 
drug markets.
I Intelligence-led policing
Effective cooperation mechanisms for the EU and its MS and 
the development of intelligence-led policing are central to the 
EU’s approach to tackling organised crime. Europol is at the 
core of the EU’s use of intelligence-led policing and it works 
with Interpol and other police forces internationally to reduce 
the supply of illicit drugs and target organised crime groups 
involved in their production and trafficking. Europol’s SOCTA 
and other intelligence reports and threat assessments are 
used as priority-setting tools for the Council’s working groups 
in defining which crime areas need to be urgently addressed. 
As already explained, EMPACT is a coordination platform 
for the EU MS and institutions to implement operational 
(2) See http://www.emcdda.europa.eu/activities/action-on-new-drugs
law enforcement actions, supporting defined EU-level 
crime priorities from the policy cycle. Bringing together 
representatives from the MS, EU agencies, public and private 
organisations, and third countries, it is multidisciplinary in 
nature. It is here that the crime priorities agreed by the MS 
representatives at COSI are implemented by National EMPACT 
Coordinators.
I Legal measures
The EU has adopted legislative tools that allow MS to work 
together to address cross-border criminal activities such as 
the production and trafficking of drugs. Legislation has been 
designed to discourage and disrupt drug smuggling and 
bring organised crime groups to justice (Table 2). A response 
to the emergence of NPS involving a three-step process 
of information exchange, risk assessment and control has 
been implemented, resulting in EU-wide bans on certain 
drugs. The processes involved in criminal investigations and 
judicial proceedings are supported by several legal acts. Legal 
provisions have been made for the use of controlled deliveries 
of drugs during investigations, the use of joint investigation 
teams, European arrest warrants and European evidence 
warrants, and agreement on the elements that constitute the 
criminal act of drug trafficking and its punishment.
The timely and efficient exchange of information to support 
policing lies at the core of cooperation between law enforcement 
TABLE 2
EU legislation related to drug supply reduction
Risk assessment and control of new psychoactive substances
Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances
Council Implementing Decision of 25 September 2014 on subjecting 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 
3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-
(ethylamino)cyclohexanone (methoxetamine) to control measures (2)
Forensic analysis and criminal investigation
Council Decision of 28 May 2001 on the transmission of samples of controlled substances (2001/419/JHA)
Council Recommendation of 30 March 2004 regarding guidelines for taking samples of seized drugs (2004/C 86/04)
Information exchange
Council Framework Decision 2006/960/JHA of 18 December 2006 on simplifying the exchange of information and intelligence between law 
enforcement authorities of the Member States of the European Union (‘the Swedish Initiative’)
Council Decision 2008/615/JHA of 23 June 2008 on the stepping up of cross-border cooperation, particularly in combating terrorism and cross-border 
crime (‘Prüm Decision’)
Judicial and police cooperation in criminal matters
Council Act of 29 May 2000 establishing in accordance with Article 34 of the Treaty on European Union the Convention on Mutual Assistance in 
Criminal Matters between the Member States of the European Union (2000/C 197/01)
Council Framework Decision of 13 June 2002 on joint investigation teams (2002/465/JHA)
Council Framework Decision of 13 June 2002 on the European arrest warrant and the surrender procedures between Member States (2002/584/JHA)
Council Framework Decision 2004/757/JHA of 25 October 2004 laying down minimum provisions on the constituent elements of criminal acts and 
penalties in the field of illicit drug trafficking
Council Framework Decision 2008/841/JHA of 24 October 2008 on the fight against organised crime
Council Framework Decision 2008/978/JHA of 18 December 2008 on the European evidence warrant for the purpose of obtaining objects, documents 
and data for use in proceedings in criminal matters
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agencies. A number of legal acts have been adopted to facilitate 
better flows of information between MS competent authorities. 
For example, the so-called Swedish Initiative, which replaced 
related articles in the Convention implementing the Schengen 
Agreement, ensures that the rules governing the exchange of 
information between MS can be no more constraining than 
national-level standards. The Prüm Decision made provision 
for the automated exchange of information (DNA, fingerprints, 
vehicle registrations) needed for criminal investigations and 
the participation of MS law enforcement personnel in joint 
operations in the territory of another MS.
I Regulating drug precursors
The production of pharmaceuticals, perfumes, plastics, 
cosmetics and other products involves the use of chemicals 
that can also be used for the illicit manufacture of drugs. 
For example, the manufacture of plastics, textiles, dyes, 
photochemical agents, perfumes and cigarette filters 
requires the use of the acetylating agent acetic anhydride. 
This chemical is also a reaction agent used in illicit heroin 
production, with between a litre and a half of acetic anhydride 
needed to produce a kilogram of heroin. The trade in drug 
precursors has been regulated at both the UN and EU levels to 
facilitate legitimate uses and prevent diversion. Article 12 of 
the 1988 Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances calls for signatories to control and 
monitor the trade in drug precursors. At the EU level, Article 12 
is implemented through two regulations that control the trade 
between EU MS and between the EU and third countries:
 § Regulation (EC) No 111/2005 on trade in drug precursors 
between EU and third countries, amended by Regulation 
(EU) No 1259/2013;
 § Regulation (EC) No 273/2004 on trade in drug precursors 
within the EU, amended by Regulation (EU) No 1258/2013.
The EU has also developed closer cooperation through 
bilateral agreements with 11 countries (Bolivia, Chile, China, 
Colombia, Ecuador, Mexico, Peru, Russia, Turkey, the United 
States of America and Venezuela). Through these agreements 
the EU and its partners cooperate in monitoring, exchanging 
information and providing mutual administrative assistance 
(European Commission, 2016a; 2016b; 2016c).
I Pursuing the proceeds of crime
Denying organised crime groups the profits from drug 
trafficking is an important EU policy priority. Both the European 
Agenda on Security (2015–20) and the EU action plan on 
drugs (2013–16) support measures against criminal assets 
through enhanced judicial cooperation in cross-border money 
laundering cases and the development of EU legislation 
on asset confiscation and recovery and money laundering 
(European Commission, 2015b; Council of the European 
Union, 2013a). A basis exists from which MS authorities can 
cooperate in targeting the proceeds of crime at all stages 
of their movement (identification, tracking, freezing, seizing 
and confiscation) and protect their financial systems (see 
Table 3). EU legislative tools against money laundering 
were strengthened in 2015 with the launch of a directive on 
preventing financial systems being used for money laundering 
or terrorist financing and a regulation on information 
accompanying fund transfers (European Parliament and the 
Council of the European Union, 2015a; 2015b).
The European Commission works with different organisations, 
committees and networks to develop and implement 
anti-money laundering responses. It is a member of the 
international Financial Action Task Force (FATF) and EU 
measures against money laundering are built on the 
best practice developed by the Task Force. The European 
Commission is also assisted in its work by the Expert Group 
on Money Laundering and Terrorist Financing, the Committee 
on the Prevention of Money Laundering and Terrorist 
Financing and the Joint Committee of European Supervisory 
Authorities. It also works with the informal network of EU 
financial intelligence units (FIUs) and the EU agencies Europol 
and Eurojust also support the EU’s anti-money laundering 
measures (European Commission, 2015e).
Given the cross-border nature of money laundering, regional 
and international networks play an important role in facilitating 
action against the assets of drug traffickers. Europol provides 
TABLE 3
EU legislation targeting the proceeds of crime 
(in chronological order)
Council Decision of 17 October 2000 concerning arrangements for 
cooperation between financial intelligence units of the Member States 
in respect of exchanging information
Council Framework Decision of 26 June 2001 on money laundering, 
the identification, tracing, freezing, seizing and confiscation of 
instrumentalities and the proceeds of crime (2001/500/JHA)
Council Framework Decision 2005/212/JHA of 24 February 2005 on 
confiscation of crime-related proceeds, instrumentalities and property
Council Decision 2007/845/JHA of 6 December 2007 concerning 
cooperation between asset recovery offices of the Member States in 
the field of tracing and identification of proceeds from, or other property 
related to, crime
Regulation (EU) 2015/847 of the European Parliament and of the 
Council of 20 May 2015 on information accompanying transfers of 
funds and repealing Regulation (EC) No 1781/2006
Directive (EU) 2015/849 of the European Parliament and of the Council 
of 20 May 2015 on the prevention of the use of the financial system for 
the purposes of money laundering or terrorist financing
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permanent support to the CARIN, which includes EU MS. 
Covering more than 50 jurisdictions, the informal network 
is connected with other asset recovery networks around the 
world and assists in asset recovery proceedings. It addresses 
all stages of the process of asset recovery including asset 
tracing, freezing and seizing, management, confiscation/
forfeiture and sharing (Europol, 2013).
Eurojust works with EU MS to target money laundering. 
It facilitates and supports cross-border investigations. In 
2014 there were 220 money laundering cases registered with 
Eurojust. Often, cases in this area are dealt with alongside 
fraud and participation in organised crime group membership 
offences (Eurojust, 2015b). For example, in 2013 a Spanish 
and Belgian police operation targeted a drug trafficking and 
money laundering network. Alongside 5 301 kg of cannabis, 
two fishing boats, 77 vehicles, 20 buildings and five companies 
were among the assets seized totalling EUR 13.7 million. 
Eurojust funded operational meetings, produced a range 
of analytical reports (forensic, operational, social network 
analysis) and deployed its mobile office and Universal Forensic 
Extraction Device to analyse mobile phones (Eurojust, 2015c).
I Financial tools
As part of its comprehensive drug supply reduction approach, 
the EU finances a wide range of activities within and outside 
the EU. Financial instruments with a broad focus are used 
to implement the drug supply reduction, international 
cooperation and other objectives of the EU drugs strategy 
(2013–20) and its action plan (2013–16) (see Table 4). 
These instruments fall into four categories: framework 
programmes (e.g. the Internal Security Fund), programmes 
for EU candidate and potential candidate countries (e.g. 
Instrument for Pre-accession Assistance), geographic or 
regional programmes (e.g. European Neighbourhood Policy), 
and specific programmes that complement geographic ones 
(e.g. Instrument contributing to Stability and Peace). The 
tools are funded through the EU budget and in cooperation 
with consortiums of MS and international partners (European 
Commission, 2015f; 2015g; 2015h; 2015i).
I Maritime initiatives
Organised crime groups frequently attempt to move illicit 
drug shipments by sea, either through their own ships or via 
legitimate commercial vessels that carry cargo containers. 
As more than 70 % of the EU’s external borders are maritime, 
illicit drug smuggling at sea poses a significant challenge. 
The European Agenda on Security (2015–20), the EU drugs 
strategy (2013–20), and the European Maritime Security 
Strategy seek to target maritime drug trafficking (Council of the 
European Union, 2012a; 2014a; 2014b; European Commission, 
2015a). A number of broad and targeted measures adopted by 
the EU and its MS support the implementation of these policies 
and play a role in increasing maritime security and reducing the 
possibility for illicit drug smuggling.
Maritime interdiction, like all forms of maritime security and 
safety, is based on solid information-sharing networks. The 
ongoing development of the Common Information Sharing 
Environment for Maritime Surveillance in Europe (Maritime 
CISE) seeks to strengthen the security capabilities of the 
European maritime domain. As a voluntary information-sharing 
tool, the Maritime CISE aims to build on EU MS’ existing 
information systems. It provides access to an almost 
real-time situational awareness that includes a European 
list of suspicious vessels of all types and sizes, automated 
cross-border exchange of MS ship registry data, and a traffic 
picture based on merged civilian and military tracking systems. 
While designed with a broad purpose and supporting increased 
interoperability in EU information systems, the Maritime CISE 
will contribute to making the EU a difficult maritime smuggling 
environment for drug traffickers (European Commission, 2014a).
The economies of the EU and its partners are reliant on secure 
and reliable supply chains to support global trade. The Container 
Security Advanced Information Networking (CONTAIN) project 
demonstrated the operation of an EU surveillance system for 
shipping containers. It was designed to assist supply chain 
operators with, for example, risk profiling of containers through 
making the history of a specific container’s movements 
available and installing container-integrated sensors (European 
Commission, 2011). While CONTAIN ran between 2011 and 
2015, the lessons from it and similar projects have been taken 
TABLE 4
EU financial instruments supporting drug supply 
reduction
EU internal action
The Internal Security Fund (ISF)
 § ISF Borders and Visa
 § ISF Police
The Justice Programme
The EU Health Programme
Horizon 2020
EU external action 
Instrument contributing to Stability and Peace (IcSP)
Instrument for Pre-accession Assistance (IPA II)
European Neighbourhood Policy (ENP)
 § European Neighbourhood and Partnership Instrument
 § TAIEX (Technical Assistance and Information Exchange)
Development and Cooperation Instrument (DCI)
European Development Fund 
European Instrument for Democracy and Human Rights 
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forward by the CORE project. It aims to demonstrate that 
a Consistently Optimised REsilient (CORE) ecosystem can 
guarantee the secure transit of goods in the global supply chain. 
The project aims to consolidate the solutions developed during 
projects such as CONTAIN (European Commission, 2015d).
The European Borders Surveillance System (Eurosur) is 
designed to enhance situational awareness and reaction 
capabilities at the EU’s external borders in order to counter 
cross-border crime and irregular migration. National 
Coordination Centres (NCCs) bring together the range of 
national authorities responsible for border security in one 
team and share information with other MS and Frontex. Based 
on the situational data from NCCs, Frontex develops the 
European situational picture and the pre-frontier intelligence 
picture beyond the Schengen area and EU borders. Eurosur 
has allowed the intelligence resources and interception 
capabilities of different EU MS and Schengen countries to be 
used in a complementary way to interdict illicit drug smugglers. 
Currently covering all Schengen area countries as well as 
Bulgaria, Croatia and Romania, Eurosur is supported by an 
indicated budget of EUR 244 million between 2014 and 2020 
(European Commission, 2014b).
Organised crime groups are subject to significant financial 
losses when bulk shipments of illicit drugs are interdicted. 
Given the strategic importance of the Atlantic Ocean to drug 
traffickers seeking to smuggle their products into Europe, the 
Maritime Analysis Operations Centre — Narcotics (MAOC-N) 
was established in 2007. This was the result of an initiative 
taken by seven EU MS (Ireland, Spain, France, Italy, the 
Netherlands, Portugal and the United Kingdom) when they 
came together to sign an inter-governmental treaty. The 
European Commission provides funding for MAOC-N, which 
is based in Portugal. A range of national services (police, 
customs, military and maritime authorities) are represented by 
Country Liaison Officers at MAOC-N, while the United States 
of America is also represented by a permanent observer from 
the Drug Enforcement Administration. Operations supported 
by MAOC-N resulted in the seizure of more than 80 tons of 
cocaine and over 250 tons of cannabis between 2007 and July 
2014. MAOC-N is involved in the operational action plans of 
the EU policy cycle (MAOC-N, 2015).
I Targeting international drug trafficking
Today’s globalised world is characterised by the operation 
of extensive international trade routes and the infrastructure 
that supports it at the national level. Organised crime groups 
readily exploit land, sea and air networks in order to move 
production materials and illicit drugs. The EU is involved in 
several international initiatives with different organisations and 
countries aimed at disrupting these criminal activities. Both 
the EU drugs strategy (2013–20) and its action plan (2013–
16) designate international cooperation as an important 
cross-cutting issue. The EU is involved in a range of projects 
and initiatives around the world designed to reduce the 
supply of illicit drugs. It does this by supporting and working 
with different partners. For example, the EU contributes to 
action against the production and trafficking of drugs through 
its financial support via the European Commission for the 
UNODC. Below, we describe some of the main responses 
being undertaken by the EU and its international partners.
I The Container Control Programme
Maritime shipping lies at the heart of today’s global economy. 
As many goods spend some portion of their transit in sea-bound 
vessels, the movement of cargo containers is a significant global 
industry, with 500 million shipped annually (UNODC and WCO, 
2015a). Established and busy maritime routes are often targeted 
by organised crime groups trying to get manufacturing materials 
(precursor chemicals) and illicit drugs to production sites and 
drug markets. The Cargo Container Programme (CCP) is a joint 
initiative operated by the UNODC and the World Customs 
Organization (WCO) aimed at capacity building. Several EU 
MS and the European Commission are financial donors for 
the programme. It currently has 40 participating countries. 
Through the programme Port Control Units (PCUs) staffed with 
law enforcement specialists are established close to container 
terminals. The CCP contributes training and equipment and 
facilitates collaborative working. PCUs are assisted in their work 
by a number of WCO tools. The ContainerComm system enables 
secure communication between PCUs and has 700 active 
users worldwide, while the Container Targeting System provides 
automated risk profiling. The CCP was established in 2004 and 
between then and 2014 some 100 tons of cocaine, almost 
three tons of heroin, 60 tons of cannabis and 1 275 tons of drug 
precursors were seized by PCUs. (UNODC and WCO, 2015). In 
2015, some 26 173 kg of cocaine (85 seizures), 440 kg of heroin 
(16 seizures), 3 679 kg of cannabis (16 seizures) and 58 360 
litres of drug precursors (two seizures) were seized (UNODC and 
WCO, 2016).
I The Cocaine Route Programme
Since 2009 the European Commission has been working 
with its international partners to implement the Cocaine 
Route Programme. Through the Instrument contributing to 
Stability and Peace (IcSP), the Commission has contributed 
roughly EUR 50 million to the programme, supporting the 
implementation of projects in over 40 countries. The programme 
seeks to support regional and trans-regional law enforcement 
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and judicial cooperation in countries on the cocaine trafficking 
route. It does this through projects that address drug 
interdiction, targeting the proceeds of crime and enhancing 
information exchange (European Commission, 2015j).
Three of the Cocaine Route projects focus on cocaine 
trafficking: the Airport Communication Programme (AIRCOP), 
the Seaport Cooperation Programme (SEACOP) and 
Prevention of the diversion of drugs precursors in the Latin 
American and Caribbean region (PRELAC). AIRCOP seeks 
to disrupt drug trafficking in origin and transit countries by 
strengthening the interdiction capacity of international airports 
in African and Latin American and Caribbean countries. 
Set to run between January 2010 and December 2016, the 
programme is being implemented by the Commission with 
UNODC, INTERPOL and the WCO. Under the programme 
Joint Airport Interdiction Task Forces (JAITFs) are established 
and the WCO’s CENcomm communication system and 
INTERPOL’s I-24/7 system are installed at key airports. JAITFs 
have seized 614 kg of cocaine, 449 kg of cannabis, 83 kg 
of heroin, 336 kg of methamphetamines and 1 396 kg of 
counterfeit drugs as of February 2015 (European Commission, 
2015k). SEACOP helps countries tackle maritime trafficking. 
It is being implemented between July 2010 and December 
2016 in West African and Eastern Caribbean countries 
by the Commission and a consortium of EU MS including 
Spain, France, Portugal and the United Kingdom. Through 
the provision of equipment and training SEACOP supports 
the establishment of maritime control and intelligence units, 
the enhancement of information systems and improved 
operational cooperation. Some 24 training courses had been 
delivered, seven Joint Maritime Control Units established, 
and four regional workshops held by March 2015 (European 
Commission, 2015l). PRELAC focused on stopping the 
diversion of drug precursors and non-scheduled chemical 
substances from licit purposes to drug production. The project 
was implemented by the Commission and UNODC between 
March 2009 and February 2016 in Central and Latin American 
countries. The project was supporting the development of 
a regional-level precursor information-sharing system, building 
inter-agency cooperation, and the involvement of the private 
sector in national and regional prevention measures. Some 3 
649 people had been trained at 109 events, 18 colloquia held 
with the private sector and 10 studies undertaken by March 
2015 (European Commission, 2015m).
Facilitating law enforcement and judicial information exchange 
is addressed by two Cocaine Route Programme projects: 
Facilitating the collection, centralisation, management, 
sharing and analysis of police information in West Africa 
Police Information System (WAPIS) and a programme to 
strengthen cooperation of law enforcement, judicial and 
prosecuting authorities in Latin America and the Caribbean 
(AMERIPOL-EU). WAPIS was designed to assist West 
African police forces respond to drug trafficking through the 
construction of a regional-level police information system 
that has global links. The initial pilot to develop WAPIS was 
implemented by the Commission and INTERPOL and involved 
four countries and ran from September 2012 to October 
2015. The project supported the establishment of national 
data collection centres and the operational and functional 
environment needed to support the collection and registration 
of data. By March 2015 some 10 000 existing paper-based 
police files had been scanned into the system, with INTERPOL 
Country Offices regularly providing assistance (European 
Commission, 2015n). The AMERIPOL-EU project was aimed 
at improving the exchange of police information and judicial 
cooperation in regional and trans-regional investigations. 
Running between January 2011 and December 2015, the 
project was implemented by the European Commission and 
a consortium of EU MS including Spain, Portugal, the United 
Kingdom and Italy. AMERIPOL Units have been established in 
six countries and best practices such as JITs and the use of 
Intelligence Working Files are being promoted alongside the 
creation of a secure information exchange platform. To date 
over 850 kg of cocaine and over EUR 11 million in cash, boats, 
vehicles and property have been seized as a result of the 
project (European Commission, 2015o).
The proceeds of crime are targeted by two of the Cocaine 
Route Programme’s projects: Supporting anti-money 
laundering and financial crime initiatives in West Africa 
(AML-WA) and Supporting anti-money laundering and 
financial crime initiatives in Latin America (GAFILAT-EU). 
AML-WA aimed to establish anti-money laundering measures 
in the non-banking financial and designated non-financial 
business and professions areas in four participating 
countries, as well as strengthening the capacity of FIUs. 
The project ran between January 2013 and June 2015 and 
was implemented by the Commission and a consortium of 
EU MS including Spain, France and the United Kingdom. 
It improved knowledge of the anti-money laundering 
situation in the concerned sectors facilitated better access 
to analytics for FIUs, and facilitated experience of financial 
investigations compliant with the FATF recommendations 
and interaction with other countries and agencies involved 
in asset recovery. A total of 125 people were trained during 
the project in 11 training missions, 12 assessment missions 
were undertaken and four expert roundtable sessions were 
held (European Commission, 2015p). The GAFILAT-EU project 
seeks to strengthen the coordinated action undertaken 
by the Member States of the Financial Action Task Force 
of South America (GAFILAT) in addressing organised and 
financial crimes. It does this by improving preventative 
systems, enhancing capacities to address asset laundering 
investigations, fostering administrative, judicial and police 
cooperation, and compliance with the international standards 
of the FATF. Through the project, situational assessments of 
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money laundering legislation in the non-banking sector and 
investigative capacity have been undertaken, as have efforts 
to increase standardisation of investigation capacities, and the 
establishment of cooperation agreements. Running between 
January 2010 and December 2016 the project is implemented 
by the European Commission and GAFILAT. Up to March 2015 
some 17 training courses and 12 conferences were held, with 
1 020 officials receiving training, while four joint operations 
took place (European Commission, 2015q).
Launched in December 2015, the CRIMJUST Project’s 
objective is to enhance criminal justice cooperation and 
investigation in selected countries on the route identified by 
the Cocaine Route Programme. The project is set to run for 
four years and is designed to support criminal justice entities 
in prosecuting drug traffickers. It aims to foster inter-regional 
action against drug trafficking and to strengthen the integrity of 
criminal justice entities (European Commission, 2016d).
The Cocaine Route Monitoring and Support Project aims to 
enhance synergies between the other projects that constitute 
the Cocaine Route Programme. It is tasked with ensuring 
that the project remains coherent both internally among its 
constituent parts and externally among other EU and EU MS 
projects. It is implemented by the Commission and the Royal 
United Services Institute for Strategic Studies (European 
Commission, 2015r).
I The Heroin Route Programme
The trafficking of heroin from Afghanistan to Europe poses 
a range of shared security challenges for the EU and the 
countries smuggling routes pass through (EMCDDA and 
Europol, 2016). With funding from the IcSP, the ‘Fight against 
trafficking in human beings and organised crime along the 
Heroin Route’ programme was established to counter the 
threat posed by organised crime groups. It enables the 
EU to work in partnership with different organisations and 
governments impacted by the smuggling routes that pass 
through Afghanistan, Pakistan, the Central Asian countries, 
the Caucasus, the Black Sea Basin and the Western Balkans. 
A number of ongoing projects have been established since the 
programme’s launch in 2008 (European Commission, 2014b).
The ‘Fight against trafficking from and to Afghanistan’ project 
was set up during phase one of the programme. Its overall 
aim is to enhance the capacity of the regional agencies and 
institutions to respond to drug trafficking and engage in 
projects against smuggling. The project is being led by the 
Deutsche Gesellschaft für Internationale Zusammenarbeit 
(GIZ) GmbH on behalf of the German Federal Government. It 
is built on a partnership approach and involves the UNODC, 
Interpol and the Drug and Organized Crime Coordination 
Unit of the Economic Cooperation Organization. A budget 
of EUR 9.5 million was allocated to the project between 
2009 and 2014. The project’s first component focused on 
developing the capacity of the Drug and Organized Crime Unit 
of the Economic Cooperation Organization (ECO) so it could 
become a regional coordination platform for anti-trafficking 
measures. The second component of the programme sought 
to strengthen the National Central Bureaus established by 
INTERPOL in Afghanistan, Pakistan, and Iran to facilitate 
the further expansion of INTERPOL’s I-24/7 secure police 
communication system. Stopping the flow of drugs and drug 
precursors though the creation of a cooperation network of 
border control units in land, air and sea ports was the aim of 
component three. It was focused on Afghanistan, Azerbaijan 
and Kazakhstan and was carried out within the context of 
the UNODC and WCO’s Container Control Programme. The 
German Federal Criminal Police Office led the implementation 
of component four, which established a forensic laboratory 
network in the countries of the ECO (European Commission, 
2014b).
Three separate projects were launched during the second 
phase of the Heroin Route Programme. The ‘Heroin route II — 
container control along the heroin route’ project was aimed at 
supporting the establishment of inter-agency PCUs to facilitate 
engagement with the UNODC and WCO’s Container Control 
Programme (CCP). Focused on countries bordering the Black 
Sea (Armenia, Georgia, Republic of Moldova and Ukraine), 
EUR 1.8 million for the project was provided through the IcPS. 
The ‘Heroin route II — information networks along the heroin 
route’ project aimed to enhance law enforcement cooperation 
and coordination through developing the capacity of platforms 
such as the Central Asian Regional Information and Coordination 
Centre. Led by the International Foundation of Administration 
and Public Policies of Spain, a consortium of EU MS are involved 
in the project, which was allocated EUR 2.7 million. The ‘Support 
to the fight against trafficking in human beings in Azerbaijan, 
Bosnia and Herzegovina, Republic of Moldova and Turkey’ 
project was established to enhance information gathering and 
exchange to support cooperation on regional law enforcement. 
It is being implemented by a consortium of EU MS and the 
International Centre for Migration Policy and Development 
(European Commission, 2014b). Phase three of the Heroin Route 
Programme was launched in 2014 and is ongoing.
I Border management
The operation of modern border controls lies at the heart 
of maintaining reliable trade routes and safe and secure 
societies. The Border Management Programme in Central Asia 
aims to contribute to the security of Central Asian countries 
(Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and 
Uzbekistan). It seeks to do this by continuing to implement 
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features of integrated border management, enhancing the 
management of the movement of people and goods at border 
crossing points and developing the capacity of border agencies. 
The programme receives funding though the EU’s DCI and was 
allocated EUR 33.6 million between 2003 and 2014. Phase 
nine of the programme runs between 2014 and 2017, with 
a contribution of EUR 5.5 million from the EU and a consortium 
of EU MS (European External Action Service, 2014).
I The Paris Pact Initiative
Launched in 2003, the Paris Pact Initiative is a partnership 
involving over 70 countries and several international 
organisations to address the trafficking and consumption 
of opiates from Afghanistan. This partnership approach 
was adopted at the Ministerial Conference on Drug Routes 
from Central Asia to Europe, at which the Paris Pact was 
established. Shared responsibility for the problem was 
recognised and agreement made to increase national 
capabilities and regional partnerships against heroin 
trafficking. Two high-level meetings were subsequently held 
in Moscow and Vienna, producing declarations in 2006 and 
2012 reaffirming political support for the pact. The Vienna 
Declaration set out support for regional initiatives to address 
opiate trafficking from Afghanistan, detecting and blocking 
financial flows linked to the trade, preventing the diversion of 
drug precursors, and reducing drug abuse and dependence 
(UNODC, 2013a). UNODC performs a central role in the 
initiative, which facilitates coordination and synergies 
between other relevant projects and provides a mechanism 
for information exchange that informs policymakers. The 
Consultative Mechanism and Automated Donor Assistance 
Mechanism was established under the first phase of the 
initiative. This was aimed at improving border controls in 
West and Central Asia, supporting the establishment of legal 
and institutional structures in key countries and improving 
regional cooperation between Europe and West and Central 
Asia. During phase II, the Research and Liaison Officers 
Network was established. The analysts work with UNODC 
field office staff to construct a picture of opiate trafficking. 
The Rainbow Strategy was also launched during phase II, 
providing a framework to implement actions agreed by the 
partners on a range of issues. Among these are the three 
phases of Operation TARCET (targeted anti-trafficking 
operation in the region that will enhance communication, 
expertise and training), which have focused on precursor 
control (UNODC, 2011a; 2011b). The evaluation of phase III of 
the initiative found that it had contributed to a convergence of 
perspectives and priorities among the partners in addressing 
opiate trafficking from Afghanistan (UNODC, 2012). Phase IV 
of the initiative runs between 2013 and 2016 and provides 
continuing support for the objectives established in the Vienna 
Declaration (UNODC, 2013b).
I Action against drug precursors
The International Narcotics Control Board (INCB) is responsible 
for monitoring the global trade in drug precursors that can be 
used for the illicit manufacture of drugs. It operates several 
tools in conjunction with national governments to assist with 
its work. In participating countries, Central National Authorities 
operate the INCB’s Pre-Export Notification (PEN) system. This 
facilitates transaction visibility and monitoring of importers 
and exporters. PEN is used by national authorities to scrutinise 
suspicious incoming chemical shipments and to halt their 
movement through licit trade channels. It also operates the 
Precursors Incident Communication System, which is used to 
exchange information on operational issues, build cases, and 
gain awareness of emerging and unscheduled substances 
(INCB, 2016).
Two ongoing international projects are operated by the 
INCB’s Precursor Task Force to target the trade in drug 
precursors. Project Cohesion targets chemicals used in the 
illicit manufacture of heroin (acetic anhydride) and cocaine 
(potassium permanganate), while project Prism addresses 
chemicals used to produce amphetamine-type stimulants 
(phenylacetic acid, ephedrine and pseudoephedrine). The 
projects function as platforms for monitoring licit trade, 
preventing diversions and launching time-bound operations. 
Under the projects, Operation Eagle Eye was operated in 
two phases in 2013 and 2014 and involved 42 countries. It 
sought to verify the legitimacy of acetic anhydride shipments. 
The operation found that national controls on the trade in 
acetic anhydride are not as robust as those in place at the 
international level (INCB, 2016). This issue was one of the 
factors that resulted in the EU revision of the legislation on 
drug precursors in 2013.
I COPOLAD
The Cooperation Programme on Drug Policies (COPOLAD) is one 
of the programmes the EU uses to support cooperation with its 
partners in Latin American and Caribbean countries. COPOLAD 
was launched in 2010 and is set to run until 2019 (COPOLAD 
and COPOLAD II), with the EU allocating EUR 16.5 million to 
the programme over this period. The programme has four main 
objectives: consolidation of national observatories; capacity 
building in the reduction of demand; capacity building in the 
reduction of supply; and policy support and consolidation of 
the EU-CELAC Coordination and Cooperation Mechanism on 
Drugs. In the area of monitoring, the programme has resulted 
in the development of national drug observatories and early 
warning systems in different countries. COPOLAD training 
and information exchanges have taken place to support the 
development of monitoring indicators and information analysis. 
Two of the partners involved in implementing the programme, 
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the EMCDDA and the Inter-American Drug Abuse Control 
Commission (CICAD) of the Organization of American States 
(OAS) developed a joint handbook ‘Building a national drugs 
observatory’ (EMCDDA and CICAD-OAS, 2010). Different training 
sessions have been held on alternative development, air and 
maritime interdiction with different national officials as part 
of the supply reduction component of COPOLAD. Similarly, 
research and analytical tools for the development of supply 
reduction aspects of public policies have been created as part of 
the programme, including a manual on alternative development 
and research on air and maritime trafficking routes (European 
Commission, 2016e; 2016f).
I Alternative development
Alternative development in countries impacted by the 
cultivation, production and trafficking of illicit drugs is a core 
part of international cooperation. Action 32 of the EU drugs 
action plan (2013–16) calls for alternative development to 
be integrated into EU programming and external assistance 
through projects in source and transit countries. The European 
Commission and the EEAS operate funding instruments 
that finance projects in different countries. For example, the 
EU is actively involved in helping Afghanistan recover from 
conflict and provides financial support through the DCI. In the 
2014–20 Multi-annual Indicative Plan for Afghanistan, the 
level of indicated EU funding for the country amounts to EUR 
1.4 billion (European Commission and European External 
Action Service, 2014a). Similarly, the EU supports alternative 
development in the countries where most cocaine is produced 
(Bolivia, Colombia and Peru), and in Latin America generally, 
through the European Union and the EU-CELAC action plan 
(2013–15) (Council of the European Union, 2013b). Under 
the DCI, indicative financing for 2014–20 in the region is 
EUR 805 million for Latin America and EUR 120 million for 
subregional cooperation with Central America. Drug issues 
are, for example, part of the programming covering the 
Security-Development Nexus, with indicative funding of EUR 
70 million (European Commission and European External 
Action Service, 2014b).
I Tackling the proceeds of crime
Several organisations operate initiatives aimed at depriving 
organised crime groups of the profits from drug trafficking. 
These include international organisations such as UNODC and 
the FATF and regionally focused financial task forces that work 
together in international initiatives (see Table 5).
Established as an intergovernmental body in 1989, the FATF 
develops standards and promotes the implementation of 
legislative and regulatory tools to tackle money laundering 
and terrorist financing. Its recommendations are regarded as 
the international standard to address these financial crimes. 
EU legislative tools for targeting money laundering are, for 
example, based on FATF’s standards. FATF works to protect the 
global financial system and collaborates with other bodies and 
organisations to identify weaknesses in national systems and 
develop appropriate responses (Financial Action Task Force, 
2015). For example, it has carried out research on the financial 
flows linked to the production and trafficking of Afghan opiates 
(Financial Action Task Force, 2014).
The World Bank Group and the UNODC operate the Stolen 
Asset Recovery Initiative. It is the main international 
programme focused on the recovery of public assets stolen 
by corrupt government officials in developing countries. It 
helps countries to build their capacity to investigate cases and 
supports these efforts through the development and provision 
of knowledge and technical assistance and the facilitation 
of cooperation. Alongside developing technical manuals, 
the programme runs asset recovery training workshops 
and responds to requests to help develop institutions and 
relevant legislative tools. It is also involved in advocating for 
the implementation of asset recovery standards such as the 
United Nations Convention against Corruption (UNCAC) and 
works with the Conference of States Parties to the UNCAC 
(World Bank Group and UNODC, 2015).
I The Global SMART programme
Globally, amphetamine-type stimulants are, after cannabis, the 
second most consumed illicit drugs and the market for them is 
increasingly interlinked with the use of NPS. One response to 
the rapidly changing market place for these drugs is UNODC’s 
Global Synthetics Monitoring: Analyses, Reporting and Trends 
(SMART) programme. Launched in 2008 as a means of 
TABLE 5
Regional financial task forces targeting money laundering
Financial Action Task Force 
Caribbean Financial Action Task Force 
Financial Action Task Force against Money Laundering in South 
America 
Inter-Governmental Action Group against Money Laundering in West 
Africa 
Middle East & North Africa Financial Action Task Force 
Committee of Experts on the Evaluation of Anti-Money Laundering 
Measures and the Financing of Terrorism 
Eastern and Southern Africa ‘Anti-Money’ Laundering Group 
Eurasian group on combating money laundering and financing of 
terrorism 
Asia/Pacific Group on Money Laundering 
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providing timely updates on the drugs appearing, it is mainly 
focused on East and South-East Asia, the Pacific, the Near 
and Middle East, Latin America and Africa (UNODC, 2014a). 
The programme aims to achieve three outcomes. It seeks to 
build capacity though the provision of technical support to 
Member States to help them collect and manage data on 
synthetic drugs, such as information from law enforcement. 
SMART also aims to increase understanding of drug problems 
though widely reporting and providing early warning on the 
emerging data. It also provides support for the development 
of evidence-based drug policies though the provision of policy 
relevant information (UNODC, 2014b).
I Conclusion
Illicit drug markets are always changing and the methods 
for producing and trafficking drugs also evolve as criminals 
seek to maximise profits and evade detection. The EU and its 
international partners keep pace with these changes and take 
action on a number of fronts against those involved in the illicit 
drugs trade simultaneously. This involves adopting a range of 
measures within and outside European borders. In particular, 
it requires refining the EU law enforcement, criminal justice 
and regulatory measures in place. It also involves assisting 
partner countries to build their own capacity in these areas and 
to develop their economies and participation in international 
trade by strengthening their engagement with both the EU and 
the global economy. This provides a responsive and ongoing 
basis for targeting the production and trafficking of drugs on an 
international scale.
The range of security challenges within and outside the EU 
presented by the production and trafficking of drugs requires 
a multifaceted policy response. To produce drugs and move 
the finished products to consumers, organised crime groups 
target and compromise commercial cargo supply networks. 
The movement of illicit drugs within a country and from one 
country to another causes damage to communities and can 
contribute to the destabilisation of states, undermining the 
rule of law. Laundering the profits from illicit drugs and moving 
them between jurisdictions compromises the integrity of 
national economies and the international financial system. 
The EU has set out its response to these interconnected 
problems arising from different stages of the production and 
trafficking of drugs. These issues are, for example, addressed 
in the EU’s illicit drug, security, organised crime, maritime and 
regional cooperation strategies. This comprehensive approach 
involves the full range of EU institutions, bodies and agencies 
with a part to play working in collaboration with international 
organisations and countries around the world.
Together the actions being taken by the EU and its MS within 
their borders and the measures in place in source and transit 
countries at the centre of drug production and trafficking aim 
to tackle organised crime groups. This includes developing 
effective law enforcement structures and operations 
underpinned by strategic intelligence information. Similarly, 
enhanced border monitoring and control strengthen global 
supply chains, while at the same time closing down active 
and potential smuggling routes. Denying organised criminals 
access to drug markets is also complemented by blocking 
their use of the legal economy and financial system through 
legislative tools. Providing support to the countries impacted 
by the drugs trade is critical if they are to strengthen their legal 
economies and fend off the corruption and destabilisation 
that this trade brings. Alternative development is a critical 
component of this approach and the EU is actively involved 
in supporting countries around the world. In doing so, it helps 
them to enhance their own law enforcement and monitoring 
resources to target the drugs trade. In order to continue 
disrupting the production and trafficking of illicit drugs the 
EU and its partners are adapting responses to keep pace with 
changes in the way organised crime groups operate.
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I Abbreviations
I AIRCOP: Airport Communication Programme
I AMERIPOL-EU: programme to strengthen cooperation of law enforcement, judicial and prosecuting 
authorities in Latin America and the Caribbean
I AML-WA: Anti-Money Laundering Activities in West Africa
I CARIN: Camden Asset Recovery Inter-Agency Network
I CCP: Cargo Container Programme
I Cepol: European Police College
I CICD: Inter-American Drug Abuse Control Commission 
I CFSP: Common Foreign and Security Policy
I CONTAIN: Container Security Advanced Information Networking
I COPOLAD: Cooperation Programme on Drugs Policies
I CORE: Consistently Optimised REsilient
I COSI: Standing Committee on Operational Cooperation on Internal Security
I DCI: Development and Cooperation Instrument
I DG: Directorate-General
I ECO: Economic Cooperation Organization
I EEAS: European External Action Service
I EMCDDA: European Monitoring Centre for Drugs and Drug Addiction
I EMPACT: European Multidisciplinary Platform against Criminal Threats
I ENP: European Neighbourhood Policy
I EU: European Union
I EU-CELAC: European Union and the Community of Latin American and Caribbean States
I Eurojust: EU judicial cooperation unit
I Eurosur: European Border Surveillance System
I FATF: Financial Action Task Force
I FIUs: financial intelligence units
I Frontex: European Agency for the Management of Operational Cooperation at the External Borders 
of the Member States of the European Union
I GAFILAT: Financial Action Task Force of South America
I GAFILAT-EU: project to support anti-money laundering and financial crime initiatives in Latin 
America
I HDG: Horizontal Working Party on Drugs
I IcSP: Instrument contributing to Stability and Peace
I INCB: International Narcotics Control Board
I IPA II: Instrument for Pre-accession Assistance
I ISF: Internal Security Fund
I JAITF: Joint Airport Interdiction Task Force
I JIT: Joint Investigation Team
I MAOC-N: Maritime Analysis Operations Centre — Narcotics
I Maritime CISE: Common Information Sharing Environment for Maritime Surveillance in Europe
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I MASPs: Multi-annual Strategic Plans
I MS: Member States
I NCC: National Coordination Centre
I NPS: new psychoactive substances
I OAPs: Operational Action Plans
I OAS: Organization of American States
I PCU: Port Control Unit
I PEN: the INCB’s Pre-Export Notification system
I PRELAC: Prevention of the diversion of drugs precursors in the Latin American and Caribbean region
I SEACOP: Seaport Cooperation Programme
I SMART: Synthetics Monitoring: Analyses, Reporting and Trends
I SOCTA: Serious and Organised Crime Threat Assessment
I TAIEX: Technical Assistance and Information Exchange
I TEU: Treaty on European Union (Lisbon Treaty)
I UNCAC: United Nations Convention against Corruption
I UNODC: United Nations Office on Drugs and Crime
I WAPIS: West Africa Police Information System
I WCO: World Customs Organization
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